U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06996886) titled 'A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations' on May 21.
Brief Summary: The purpose of this study is to assess the relative bioavailability of a single dose AZD5004 in healthy participants, among 3 different oral tablet formulations.
Study Start Date: May 22
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AZD5004
Participants will be receiving three different formulations (F1, F3, and F4) as single dose of AZD5004 orally in fasted and fed state.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated...